Collagen Hemostatic Sponge
Porous Collagen Scaffold · Fluid Uptake · Platelet Interaction · Lyophilized Structure
A porous collagen-based biomaterial platform developed around controlled scaffold architecture, fluid uptake and material interaction at the bleeding interface. From formulation and prototype development to lyophilization, testing and OEM manufacturing.
Porous Collagen Scaffold
Fluid Uptake
Platelet Interaction
Lyophilized Structure
Collagen Biomaterial Platform
Our collagen hemostatic sponge platform is built around controlled scaffold architecture derived from purified collagen. The material is developed to support fluid uptake and material interaction at the bleeding interface through a defined porous structure created via lyophilization.
Porous Scaffold Architecture
Scaffold porosity is a critical parameter in hemostatic biomaterial performance. Our development process focuses on controlling pore size distribution, interconnectivity and overall scaffold architecture through formulation and freeze-drying process parameters. Scaffold architecture is characterized and documented for each development batch.
Fluid Uptake & Material Interaction
The porous collagen scaffold is designed to support rapid fluid uptake. Material interaction at the bleeding interface involves the scaffold structure, collagen surface chemistry and platelet contact. These properties are evaluated during prototype development and material characterization.
Lyophilization Process
Freeze-drying is the core manufacturing process for porous collagen scaffold formation. Controlled freezing rate, shelf temperature and drying cycle parameters directly influence scaffold architecture. Our lyophilization process development capability allows optimization of these parameters for each material formulation.
Prototype Development
Prototype development begins with material formulation, followed by casting, controlled freezing and lyophilization. Initial prototypes are characterized for scaffold architecture, fluid uptake and mechanical properties. Iterative development cycles allow optimization before scale-up.
Testing & Characterization
Material characterization includes scaffold structure analysis, porosity measurement, fluid uptake testing, mechanical property evaluation and batch documentation. Regulatory testing requirements depend on the intended application and destination market. Testing is conducted in accordance with applicable standards.
OEM Manufacturing
ShiLai™ supports qualified B2B partners with OEM manufacturing of collagen hemostatic sponge materials. Custom composition, dimensions, porosity parameters and packaging can be discussed. Scale-up from prototype to production is supported through our manufacturing platform.
Frequently Asked Questions
What is a collagen hemostatic sponge?
A collagen hemostatic sponge is a porous biomaterial scaffold produced from collagen through a lyophilization (freeze-drying) process. The porous structure supports fluid uptake and platelet interaction at the bleeding interface.
Can ShiLai™ manufacture collagen hemostatic sponges for OEM partners?
Yes. ShiLai™ supports qualified B2B partners with custom development, prototype production, lyophilization, testing and scale-up manufacturing of collagen hemostatic sponge materials.
What testing is available for collagen hemostatic sponge materials?
Available characterization and testing includes material structure analysis, fluid uptake measurement, porosity characterization, mechanical property testing and batch documentation. Regulatory testing requirements depend on the intended application and destination market.
Is this product FDA cleared or CE marked?
ShiLai™ does not claim FDA clearance, CE marking or clinical validation for this development-stage platform unless specifically documented. Regulatory requirements depend on the intended application and destination market.